Tata 1mg
Tata 1mg, founded in 2015 and headquartered in Delhi, became a unicorn in September 2022 with a $1.25 billion valuation. The company has raised $231 million across multiple funding rounds, including a $40.8 million Series D. Backed by investors such as HBM Healthcare Investments and supported by Tata Group, Tata 1mg operates an online pharmacy, doctor consultation, and diagnostic testing platform. The company focuses on improving access to affordable medicines, transparent pricing, and digital healthcare services across India.